Yangyang Yao

机构：Nanchang University, Waseda University, Xuzhou Medical College, Wenzhou Medical University, First Affiliated Hospital of Jiangxi Medical College, Jiangxi Provincial Cancer Hospital, Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, Shandong Provincial Hospital, Second People’s Hospital of Huai’an, Shandong First Medical University, First Affiliated Hospital of Nanchang University · ORCID：0000-0002-2081-1025

发表论文 73 篇 · 总被引 1286 次 · h-index 21

代表论文

• Targeting HGF/c-MET signaling to regulate the tumor microenvironment: Implications for counteracting tumor immune evasion (2025 · Cell Communication and Signaling · 被引 49)
• TMEM160 promotes tumor immune evasion and radiotherapy resistance via PD-L1 binding in colorectal cancer (2024 · Cell Communication and Signaling · 被引 21)
• TMEM160 inhibits KEAP1 to suppress ferroptosis and induce chemoresistance in gastric cancer (2025 · Cell Death and Disease · 被引 15)
• KIF18A interacts with PPP1CA to promote the malignant development of glioblastoma (2023 · Experimental and Therapeutic Medicine · 被引 13)
• Incorporation of PD-1 blockade into induction chemotherapy improved tumor response in patients with locoregionally advanced nasopharyngeal carcinoma in a retrospective patient cohort (2024 · Oral Oncology · 被引 12)
• Ubiquitin-specific peptidase 49 promotes adenocarcinoma of the esophagogastric junction malignant progression via activating SHCBP1– β -catenin–GPX4 axis (2024 · Carcinogenesis · 被引 7)